In a system where half of all clinical trials never see the light of publication, doctors are merely "imagining that we're practicing evidence-based medicine," says Ben Goldacre, MBBS, a British physician and science journalist.
Goldacre is among the most vocal critics of drugmakers who refuse to hand over complete clinical trial data, making it impossible for doctors and patients to get the full picture on most of the medicines widely used today. He decries the industry's behavior in his new book, Bad Pharma, which in itself is a review of the evidence on evidence review and the stumbling blocks incurred by researchers who try to dig deeper.
Read the full story: http://bit.ly/UVGzYR
Source: MedPage Today
Managed Care Reflections: A Q&A With A. Mark Fendrick, MD, and Michael E. Chernew, PhD
December 2nd 2025To mark the 30th anniversary of The American Journal of Managed Care (AJMC), each issue in 2025 includes a special feature: reflections from a thought leader on what has changed—and what has not—over the past 3 decades and what’s next for managed care. The December issue features a conversation with AJMC Co–Editors in Chief A. Mark Fendrick, MD, director of the Center for Value-Based Insurance Design and a professor at the University of Michigan in Ann Arbor; and Michael E. Chernew, PhD, the Leonard D. Schaeffer Professor of Health Care Policy and the director of the Healthcare Markets and Regulation Lab at Harvard Medical School in Boston, Massachusetts.
Read More